Outlook Therapeutics, Inc. (OTLK)

Outlook Therapeutics Revenue

Outlook Therapeutics had revenue of $8.70K in the quarter ending June 30, 2026, a decrease of -99.42%. This brings the company's revenue in the last twelve months to $-1.16M. In the fiscal year ending September 30, 2025, Outlook Therapeutics had annual revenue of $1.41M.

• Revenue (ttm): $-1.16M
• Revenue Growth: n/a
• P/S Ratio: -140.82
• Revenue / Employee: n/a
• Employees: 17
• Market Cap: 163.84M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2025	1.41M	-	-
Sep 30, 2024	-	-	-
Sep 30, 2023	-	-	-
Sep 30, 2022	-	-	-
Sep 30, 2021	-	-	-
Sep 30, 2020	-	-	-
Sep 30, 2019	8.15M	5.06M	163.84%
Sep 30, 2018	3.09M	-723.96K	-18.99%
Sep 30, 2017	3.81M	831.94K	27.92%
Sep 30, 2016	2.98M	-2.24M	-42.91%
Sep 30, 2015	5.22M	-3.83M	-42.33%
Sep 30, 2014	9.05M	-	-

Data Source: Fiscal.ai Last updated: Aug 18, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 11, 2026

Data Sources Report a data error